Plasma Derived Medicine Latest Market Report 2025
公開 2025/07/30 14:42
最終更新
-
Global Info Research‘s report is a detailed and comprehensive analysis for global Plasma Derived Medicine market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the Plasma Derived Medicine market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
According to our latest research, the global Plasma Derived Medicine market size will reach USD 59300 million in 2031, growing at a CAGR of 7.3% over the analysis period.
Plasma Derived Medicine: These are medicinal products that are manufactured from human plasma, the liquid component of blood. Plasma contains important proteins, clotting factors, and antibodies that can be processed and concentrated to create products used in various medical treatments. PDPs are essential for treating conditions such as hemophilia, immune deficiencies, and certain autoimmune diseases.
Driver of the Plasma Derived Medicine Market:
One of the main drivers of the Plasma Derived Medicine market is the increasing prevalence of rare and chronic diseases, such as hemophilia, primary immunodeficiency disorders, and autoimmune diseases. These conditions require ongoing treatment with Plasma Derived Medicine like clotting factors, immunoglobulins, and albumin. The growing awareness and diagnosis rates of such diseases, along with advancements in plasma collection and fractionation technologies, have contributed to a higher demand for these therapies. Additionally, increasing investments in healthcare infrastructure and government support in emerging markets are fueling market growth.
Challenge of the Plasma Derived Medicine Market:
A key challenge in this market is the complex and costly process of plasma collection and product manufacturing. Plasma Derived Medicine require large volumes of plasma, which can only be obtained through human donors. The stringent regulations surrounding plasma collection, donor screening, and testing to ensure safety make the process time-consuming and expensive. Furthermore, any disruption in plasma supply chains, such as those caused by geopolitical issues or pandemics, can lead to shortages and impact treatment availability.
The outbreak of COVID-19 pandemic has led to decrease in number of blood donations and plasma collections, which hampers the market growth as it leads to shortage in raw material supply.
The classification of Plasma Derived Medicine includes Immune Globulin, Coagulation Factor, Albumin and Other. In 2023, Immune Globulin accounted for a share of 51% in the global Plasma Derived Medicine market.
North America is the largest consumption place, with a revenue market share nearly 40% in 2023. Following North America, Europe is the second largest consumption place with the revenue market share of 24 %; China is also an important sales region for the Plasma Derived Medicine.
This report is a detailed and comprehensive analysis for global Plasma Derived Medicine market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Market segment by Type: Albumin、 Immune Globulin、 Coagulation Factor、 Others
Market segment by Application:Hospital、 Retail Pharmacy、 Other
Major players covered: Takeda、 CSL、 Grifols、 Octapharma、 Kedrion、 LFB Group、 Biotest、 BPL、 RAAS、 CBPO、 Hualan Bio、 Tiantan Bio、 Shuanglin Bio、 Boya Bio、 Yuanda Shuyang、 Weiguang Bio、 Nanyue Bio、 KM Biologics
To Get More Details About This Study, Please Click Here: https://www.globalinforesearch.com/reports/2850912/plasma-derived-medicine
The overall report focuses on primary sections such as – market segments, market outlook, competitive landscape, and company profiles. The segments provide details in terms of various perspectives such as end-use industry, product or service type, and any other relevant segmentation as per the market’s current scenario which includes various aspects to perform further marketing activity. The market outlook section gives a detailed analysis of market evolution, growth drivers, restraints, opportunities, and challenges, Porter’s 5 Force’s Framework, macroeconomic analysis, value chain analysis and pricing analysis that directly shape the market at present and over the forecasted period. The drivers and restraints cover the internal factors of the market whereas opportunities and challenges are the external factors that are affecting the market. The market outlook section also gives an indication of the trends influencing new business development and investment opportunities.
The Primary Objectives in This Report determine the size of the total market opportunity of global and key countries,assess the growth potential for Plasma Derived Medicine and competitive factors affecting the marketplace,forecast future growth in each product and end-use market. Also,this report profiles key players in the global Plasma Derived Medicine market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments.
Plasma Derived Medicine market is split by Type and by Application. For the period 2020-2031, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by region, regional analysis covers North America (United States, Canada, and Mexico),Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe),Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia),South America (Brazil, Argentina, Colombia, and Rest of South America),Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa).
The report provides insights regarding the lucrative opportunities in the Plasma Derived Medicine Market at the country level. The report also includes a precise cost, segments, trends, region, and commercial development of the major key players globally for the projected period.
The Plasma Derived Medicine Market report comprehensively examines market structure and competitive dynamics. Researching the Plasma Derived Medicine market entails a structured approach beginning with clearly defined objectives and a comprehensive literature review to understand the current landscape. Methodologies involve a mix of primary research through interviews, surveys, and secondary research from industry reports and databases. Sampling strategies ensure representation, while data analysis utilizes statistical and analytical techniques to identify trends, market sizing, and competitive landscapes. Key areas of focus include trend analysis, risk assessment, and forecasting. Findings are synthesized into a detailed report, validated through peer review or expert consultation, and disseminated to stakeholders, with ongoing monitoring to stay abreast of developments.
Global Info Research is a company that digs deep into global industry information to support enterprises with market strategies and in-depth market development analysis reports. We provides market information consulting services in the global region to support enterprise strategic planning and official information reporting, and focuses on customized research, management consulting, IPO consulting, industry chain research, database and top industry services. At the same time, Global Info Research is also a report publisher, a customer and an interest-based suppliers, and is trusted by more than 30,000 companies around the world. We will always carry out all aspects of our business with excellent expertise and experience.
Contact Us:
Global Info Research
Web: https://www.globalinforesearch.com
Email: report@globalinforesearch.com
CN: 0086-176 6505 2062
HK: 00852-58030175
According to our latest research, the global Plasma Derived Medicine market size will reach USD 59300 million in 2031, growing at a CAGR of 7.3% over the analysis period.
Plasma Derived Medicine: These are medicinal products that are manufactured from human plasma, the liquid component of blood. Plasma contains important proteins, clotting factors, and antibodies that can be processed and concentrated to create products used in various medical treatments. PDPs are essential for treating conditions such as hemophilia, immune deficiencies, and certain autoimmune diseases.
Driver of the Plasma Derived Medicine Market:
One of the main drivers of the Plasma Derived Medicine market is the increasing prevalence of rare and chronic diseases, such as hemophilia, primary immunodeficiency disorders, and autoimmune diseases. These conditions require ongoing treatment with Plasma Derived Medicine like clotting factors, immunoglobulins, and albumin. The growing awareness and diagnosis rates of such diseases, along with advancements in plasma collection and fractionation technologies, have contributed to a higher demand for these therapies. Additionally, increasing investments in healthcare infrastructure and government support in emerging markets are fueling market growth.
Challenge of the Plasma Derived Medicine Market:
A key challenge in this market is the complex and costly process of plasma collection and product manufacturing. Plasma Derived Medicine require large volumes of plasma, which can only be obtained through human donors. The stringent regulations surrounding plasma collection, donor screening, and testing to ensure safety make the process time-consuming and expensive. Furthermore, any disruption in plasma supply chains, such as those caused by geopolitical issues or pandemics, can lead to shortages and impact treatment availability.
The outbreak of COVID-19 pandemic has led to decrease in number of blood donations and plasma collections, which hampers the market growth as it leads to shortage in raw material supply.
The classification of Plasma Derived Medicine includes Immune Globulin, Coagulation Factor, Albumin and Other. In 2023, Immune Globulin accounted for a share of 51% in the global Plasma Derived Medicine market.
North America is the largest consumption place, with a revenue market share nearly 40% in 2023. Following North America, Europe is the second largest consumption place with the revenue market share of 24 %; China is also an important sales region for the Plasma Derived Medicine.
This report is a detailed and comprehensive analysis for global Plasma Derived Medicine market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Market segment by Type: Albumin、 Immune Globulin、 Coagulation Factor、 Others
Market segment by Application:Hospital、 Retail Pharmacy、 Other
Major players covered: Takeda、 CSL、 Grifols、 Octapharma、 Kedrion、 LFB Group、 Biotest、 BPL、 RAAS、 CBPO、 Hualan Bio、 Tiantan Bio、 Shuanglin Bio、 Boya Bio、 Yuanda Shuyang、 Weiguang Bio、 Nanyue Bio、 KM Biologics
To Get More Details About This Study, Please Click Here: https://www.globalinforesearch.com/reports/2850912/plasma-derived-medicine
The overall report focuses on primary sections such as – market segments, market outlook, competitive landscape, and company profiles. The segments provide details in terms of various perspectives such as end-use industry, product or service type, and any other relevant segmentation as per the market’s current scenario which includes various aspects to perform further marketing activity. The market outlook section gives a detailed analysis of market evolution, growth drivers, restraints, opportunities, and challenges, Porter’s 5 Force’s Framework, macroeconomic analysis, value chain analysis and pricing analysis that directly shape the market at present and over the forecasted period. The drivers and restraints cover the internal factors of the market whereas opportunities and challenges are the external factors that are affecting the market. The market outlook section also gives an indication of the trends influencing new business development and investment opportunities.
The Primary Objectives in This Report determine the size of the total market opportunity of global and key countries,assess the growth potential for Plasma Derived Medicine and competitive factors affecting the marketplace,forecast future growth in each product and end-use market. Also,this report profiles key players in the global Plasma Derived Medicine market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments.
Plasma Derived Medicine market is split by Type and by Application. For the period 2020-2031, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by region, regional analysis covers North America (United States, Canada, and Mexico),Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe),Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia),South America (Brazil, Argentina, Colombia, and Rest of South America),Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa).
The report provides insights regarding the lucrative opportunities in the Plasma Derived Medicine Market at the country level. The report also includes a precise cost, segments, trends, region, and commercial development of the major key players globally for the projected period.
The Plasma Derived Medicine Market report comprehensively examines market structure and competitive dynamics. Researching the Plasma Derived Medicine market entails a structured approach beginning with clearly defined objectives and a comprehensive literature review to understand the current landscape. Methodologies involve a mix of primary research through interviews, surveys, and secondary research from industry reports and databases. Sampling strategies ensure representation, while data analysis utilizes statistical and analytical techniques to identify trends, market sizing, and competitive landscapes. Key areas of focus include trend analysis, risk assessment, and forecasting. Findings are synthesized into a detailed report, validated through peer review or expert consultation, and disseminated to stakeholders, with ongoing monitoring to stay abreast of developments.
Global Info Research is a company that digs deep into global industry information to support enterprises with market strategies and in-depth market development analysis reports. We provides market information consulting services in the global region to support enterprise strategic planning and official information reporting, and focuses on customized research, management consulting, IPO consulting, industry chain research, database and top industry services. At the same time, Global Info Research is also a report publisher, a customer and an interest-based suppliers, and is trusted by more than 30,000 companies around the world. We will always carry out all aspects of our business with excellent expertise and experience.
Contact Us:
Global Info Research
Web: https://www.globalinforesearch.com
Email: report@globalinforesearch.com
CN: 0086-176 6505 2062
HK: 00852-58030175
Global Info Research is a report publisher, a customer, interest-based suppliers. Is in the best interests of our clients, they determine our every move. At the same time, we have great respect for the views of customers. With the improvement of the quality of our research, we develop custom interd…
最近の記事
タグ